The immune system strikes back
Copenhagen, Denmark – November 9, 2016: Professor Mads Hald Andersen, CSO of IO Biotech and Director of CCIT (Center for Cancer Immune Therapy) at University of Copenhagen Herlev Hospital in Denmark, will be speaking at the SITC Conference in Maryland this week.
Friday November 11 at 4:50p.m. Mads will be presenting the newest science, insights and innovation to the cancer immunotherapy community under the title: The Immune System Strikes Back: T Cells Recognizing Indoleamine 2,3-Dioxygenase (IDO) or PD-L1.
Welcoming more than 2,400 people from across the globe, SITC is well established as the premier destination for scientific exchange, education and networking in the cancer immunotherapy field.